Literature DB >> 20153607

P50 gating in deficit and nondeficit schizophrenia.

José Luis Santos1, Eva María Sánchez-Morla, Ana Aparicio, María Angeles García-Jiménez, Clara Villanueva, Vicente Martínez-Vizcaíno, Celso Arango.   

Abstract

Dysfunctional auditory sensory processing has generally been found in schizophrenia and it has been suggested that these deficits might be related to clinical and psychosocial variables. The present study included P50 recordings using a simple-paired click auditory evoked potential paradigm in sixty patients with deficit schizophrenia (DS), sixty patients with nondeficit schizophrenia (NDS), and sixty comparison subjects. The Schedule for the Deficit Syndrome was used to categorize patients as DS or NDS. The two patient groups did not differ in clinical variables, except for higher negative dimension and lower community outcome scores in DS than in NDS patients. There were no differences in P50 ratios between deficit and nondeficit subgroups; compared with normal subjects both groups of schizophrenia patients showed impaired P50 ratios (p<0.0001). This ratio appears to be independent of positive and negative symptoms. However, impairment in P50 gating correlated with poorer community outcome. The data document the existence of early auditory sensory processing abnormalities in DS and NDS, and might suggest that common neuronal network abnormalities underlie both forms of schizophrenia. Deficient P50 gating may be associated with impaired functional outcome in schizophrenia. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153607     DOI: 10.1016/j.schres.2010.01.010

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Progress in the study of negative symptoms.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

2.  Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia.

Authors:  Holly K Hamilton; Terrance J Williams; Joseph Ventura; Leland J Jasperse; Emily M Owens; Gregory A Miller; Kenneth L Subotnik; Keith H Nuechterlein; Cindy M Yee
Journal:  Am J Psychiatry       Date:  2017-12-05       Impact factor: 18.112

Review 3.  Primary, Enduring Negative Symptoms: An Update on Research.

Authors:  Brian Kirkpatrick; Armida Mucci; Silvana Galderisi
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

4.  Is the Prevalence of the Deficit Syndrome in Schizophrenia Higher than Estimated? Results of a Meta-Analysis.

Authors:  Álvaro López-Díaz; Ignacio Lara; Guillermo Lahera
Journal:  Psychiatry Investig       Date:  2018-01-16       Impact factor: 2.505

5.  Discovery biology of neuropsychiatric syndromes (DBNS): a center for integrating clinical medicine and basic science.

Authors:  Biju Viswanath; Naren P Rao; Janardhanan C Narayanaswamy; Palanimuthu T Sivakumar; Arun Kandasamy; Muralidharan Kesavan; Urvakhsh Meherwan Mehta; Ganesan Venkatasubramanian; John P John; Odity Mukherjee; Meera Purushottam; Ramakrishnan Kannan; Bhupesh Mehta; Thennarasu Kandavel; B Binukumar; Jitender Saini; Deepak Jayarajan; A Shyamsundar; Sydney Moirangthem; K G Vijay Kumar; Jagadisha Thirthalli; Prabha S Chandra; Bangalore N Gangadhar; Pratima Murthy; Mitradas M Panicker; Upinder S Bhalla; Sumantra Chattarji; Vivek Benegal; Mathew Varghese; Janardhan Y C Reddy; Padinjat Raghu; Mahendra Rao; Sanjeev Jain
Journal:  BMC Psychiatry       Date:  2018-04-18       Impact factor: 3.630

6.  Abnormal Entropy Modulation of the EEG Signal in Patients With Schizophrenia During the Auditory Paired-Stimulus Paradigm.

Authors:  Jie Xiang; Cheng Tian; Yan Niu; Ting Yan; Dandan Li; Rui Cao; Hao Guo; Xiaohong Cui; Huifang Cui; Shuping Tan; Bin Wang
Journal:  Front Neuroinform       Date:  2019-02-19       Impact factor: 4.081

7.  Neural effects of auditory distraction on visual attention in schizophrenia.

Authors:  Jason Smucny; Donald C Rojas; Lindsay C Eichman; Jason R Tregellas
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.